Clinical reactogenicity of intradermal bacille Calmette-Guerin vaccination

Clinical Infectious Diseases

Volumn 28, Issue 4, 1999, Pages 785-792

  Hoft, D F ^a   Leonardi, C ^a   Milligan, T ^a   Nahass, G T ^a   Kemp, B ^a   Cook, S ^a   Tennant, J ^a   Carey, M ^a   Ernst, J D ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BCG VACCINE; CONNAUGHT BCG; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BCG VACCINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; INFECTION RISK; INJECTION; INTERFERON PRODUCTION; INTRADERMAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SKIN ULCER; TUBERCULOSIS;

EID: 0032958395     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515201     Document Type: Article

References (0)